Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Join
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Toolkit
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Join
FREE
Edition
European
US
Rheumatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Evolving Strategies in Lupus Care
5
Mins
May 2025
Systemic lupus erythematosus (SLE) is a complex autoimmune disease that remains challenging to diagnose and treat. In this interview…
Read more
9
Mins
15 Jul 2021
Striking the Right Balance in Anti-neutrophil Cytoplasmic Antibody-Associated Vasculitis
AAV are a type of small-vessel necrotising vasculitis that manifest as systemic diseases, with pulmonary; ear, nose, and throat; and renal involvement. The key pathological feature of AAV is the presence of ANCA, which can target two neutrophil antigens, myeloperoxidase (MPO) and proteinase 3 (PR3).
6
Mins
15 Jul 2021
Interview: Christopher Edwards
Christopher Edwards | Professor and Consultant Rheumatologist and Honorary Chair of Clinical Rheumatology; Musculoskeletal Research Unit…
6
Mins
15 Jul 2021
Interview: Karen Walker-Bone
Karen Walker-Bone | Professor and Honorary Consultant in Occupational Rheumatology, University of Southampton; Director, Arthritis Research…
10
Mins
15 Jul 2021
Editor’s Pick: Management of Pregnancy in Rheumatic Disease
Many patients with rheumatic diseases (RMD) are diagnosed during their childbearing years.1 Historically, females with RMDs were advised to avoid pregnancy due to potential risk to both mother and fetus.
11
Mins
15 Jul 2021
Clinical Manifestations and Diagnosis of Behçet’s Syndrome
Behçet’s syndrome (BS) was first described by Hulusi Behçet in 1931, as a definite clinical entity, the ‘triple symptom complex’, based on three prominent signs: relapsing oral apthae, genital ulcerations, and iritis.
10
Mins
15 Jul 2021
Axial Spondyloarthritis: Clinical Characteristics, Epidemiology, and General Approaches to Management
Axial spondyloarthritis (axSpA) is a chronic inflammatory condition that predominantly affects the sacroiliac joints and spine. It is a…
14
Mins
15 Jul 2021
Treat to Target in Spondyloarthritis: Myth or Reality?
A treat-to-target (T2T) strategy is a treatment plan in which the clinician treats the patient aggressively enough to reach and maintain explicitly specified and sequentially measured goals, such as remission, low disease activity, or absence of disability.
12
Mins
15 Jul 2021
A Worthwhile Measurement of Early Vigilance and Therapeutic Monitor in Axial Spondyloarthritis:
To examine clinical application of QSS, the authors developed a search strategy of QSS using a literature review through database of MEDLINE, Embase (Ovid), CINAHL (EBSCOhost), HaPI (Ovid), Cochrane Review (Ovid), and citation mining.
11
Mins
15 Jul 2021
The Interplay of Genes with the Gut Microbiota in the Aetiopathogenesis of Spondyloarthropathies
The spondyloarthropathies (SpA) are a spectrum of inter-related conditions that include axial spondyloarthritis (AxSpA), (also known as ankylosing spondylitis; AS), non-radiographic axial spondyloarthritis, peripheral spondyloathritis (pSpA), reactive arthritis (ReA), and enteropathic arthritis associated with Crohn’s disease (CD).
9
Mins
17 Jun 2021
Prevalence of Scoliosis in Hypermobile Ehlers-Danlos Syndrome
The main purpose of this study was to evaluate the prevalence, form, and severity of scoliosis in a population of adults meeting the 2017 criteria for hypermobile Ehlers-Danlos syndrome (hEDS).
6
Mins
24 May 2021
Musculoskeletal Brucellosis in Adults in the United Arab Emirates: A Retrospective Study
Brucellosis is a zoonotic infection, historically known as Maltese fever, caused by aerobic Gram-negative coccobacilli, which was first identified by Sir…
7
Mins
22 Mar 2021
Performance of Different Criteria Sets for Inflammatory Back Pain in Radiographic
It is important to recognise inflammatory back pain (IBP) for early diagnosis of ankylosing spondylitis (AS). The aims of this study were to develop….
10
Mins
19 Feb 2021
Diagnosis, Treatment Management, and the Genetic Basis of Psoriasis, Psoriatic Arthritis, and Spondyloarthritis
Psoriatic arthritis (PsA) is an inflammatory condition of the joints and the areas where tendons and ligaments connect with bone…
9
Mins
10 Dec 2020
Optimising Response to Advanced Therapies in Rheumatoid Arthritis - Using Prehabilitation to Improve Success?
This article explores applying the principle of prehabilitation to patients with rheumatoid arthritis prior to starting advanced therapies, including…
10
Mins
10 Dec 2020
Longitudinal Characterisation of the Gastrointestinal Tract Microbiome in Systemic Sclerosis
To evaluate changes in microbial composition and the evolution of gastrointestinal tract (GIT) symptoms in systemic sclerosis (SSc).
5
Mins
17 Sep 2020
Superficial Ulcerating Rheumatoid Necrobiosis Associated with Methotrexate Use in a Patient with Rheumatoid Arthritis
Rheumatoid arthritis (RA) is a systemic autoimmune condition prevalent in North America and Northern European populations with an incidence of 1%…
6
Mins
17 Sep 2020
Sjögren’s Syndrome Complicated with Type 2 Autoimmune Hepatitis: A Case Report-Based Review of the Literature
Autoimmune hepatitis is a condition closely related to autoimmune diseases. Previously, it was known to have three distinct types, which were recently…
6
Mins
26 Aug 2020
Virtual or Face-to-Face in the Post COVID-19 World?
Niccolo Machiavelli and Winston Churchill have both been credited with the advice: “Never waste the opportunity offered by a good crisis.” It would be…
12
Mins
28 Jul 2020
Raising the Bar for Optimal Management of Axial Spondyloarthritis
Dr Proft opened the symposium with the case of a 33-year-old female patient referred via the online self-referral tool ‘Bechterew Check’…
10
Mins
21 Jul 2020
Advancing the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway
This Janssen-sponsored live symposium “Advancing the Treatment of PsA: Focus on the IL-23 Pathway,” took place virtually at the European League Against…
15
Mins
21 Jul 2020
In Darwin’s Footsteps: Adaptation Through Innovation in Rheumatoid Arthritis
Prof Schett opened the session by explaining the overall theme and objectives of the symposium. Charles Darwin famously visited the Galápagos islands…
6
Mins
21 Jul 2020
Latest Highlights on Biologic Treatments for Psoriatic Arthritis from EULAR 2020
Psoriatic arthritis (PsA) is a chronic, heterogeneous, immune-mediated arthritis characterised by joint inflammation and diverse clinical manifestations…
3
Mins
21 Jul 2020
Interview: Clinical Prof Daniel Wallace
Clinical Prof Daniel Wallace | Rheumatologist, Cedars-Sinai Medical Center and Ronald Reagan UCLA Medical Center, Los Angeles, California, USA…
6
Mins
21 Jul 2020
Early Recognition and Treatment of Spondyloarthritis: A Timeless Challenge
Spondyloarthritis (SpA) is a chronic systemic rheumatic disease, the hallmark manifestation of which is inflammatory back pain, and may also involve…
9
Mins
21 Jul 2020
Editor’s Pick: Methotrexate and The Lung in Rheumatoid Arthritis
Methotrexate (MTX) is the most commonly used medication to treat RA. MTX pneumonitis (MTX-pneu) is a rare disease entity reported in MTX users.
10
Mins
21 Jul 2020
Bone Health in Rheumatoid Arthritis: What Can Studies of Bone Microarchitecture Tell Us?
Rheumatoid arthritis (RA) is associated with changes in skeletal health, including increased risk of fracture.
10
Mins
21 Jul 2020
Systemic Sclerosis
The purpose of this review is to provide a clinically focussed description of the relevant aetiopathogenesis, clinical expression of disease, approach to the assessment and treatment of Systemic Sclerosis, and highlight the recent advances and future challenges associated with this complex disease.
9
Mins
21 Jul 2020
Using Audiometry to Track Atherosclerosis: Measuring a Beneficial Effect of Methotrexate in Rheumatoid Arthritis
To correlate audiometry with atherosclerosis. Presbycusis is associated with age and atherosclerosis; a strong correlation might present opportunities to…
9
Mins
21 Jul 2020
The Role of Vitamin D in Disease Activity in Axial Spondyloarthritis
Axial spondyloarthritis (axSpA) is a chronic inflammatory disease which predominantly involves the axial skeleton and sacroiliac joints.
3
Mins
1 Apr 2020
Rheumatology in Cyprus amid the COVID-19 pandemic
In March 2020, the COVID-19 pandemic arrived in Cyprus. Suddenly, our lives and our way of life has been affected in an unprecedented way…
15
Mins
23 Jan 2020
Is There a Missing Link in Rheumatoid Arthritis Management?
Currently, rheumatologists cannot reliably predict the progression of early undifferentiated arthritis to early RA…
9
Mins
12 Dec 2019
Editor's Pick: Identifying Shared Features and Addressing Common Challenges in Clinical Trials for Chronic Inflammatory Diseases: An Overview
Chronic inflammatory diseases (CID) encompass a wide range of pathologies affecting different organs or bodily functions…
9
Mins
12 Sep 2019
Moderate Psoriatic Arthritis and Perspectives from Phosphodiesterase-4 Inhibition
Dr Queiro-Silva opened the session by proposing a definition of the moderate-severity PsA patient: patients associated with a limited number of affected…
9
Mins
12 Sep 2019
Editor’s Pick: Systemic Sclerosis: The Role of YAP/TAZ in Disease Pathogenesis
Systemic sclerosis (SSc) is a multi-system connective tissue disease characterised by excessive fibrosis, microvasculopathy, and autoimmunity…
5
Mins
12 Sep 2019
A Versatile, Low-Cost, Three-Dimensional-Printed Ultrasound Procedural Training Phantom of the Human Knee
The use of ultrasonography has been increasing across many specialties, including rheumatology…
9
Mins
12 Sep 2019
Polymyalgia Rheumatica and Seronegative Elderly-Onset Rheumatoid Arthritis: Two Different Diseases with Many Similarities
Polymyalgia rheumatica (PMR) and seronegative elderly-onset rheumatoid arthritis (SEORA) are two of the most frequent inflammatory rheumatologic diseases in elderly patients.
10
Mins
29 Jul 2019
Optimising Patient Management in Rheumatoid Arthritis: Can We Live Up to Patient Expectations?
Anti-TNF biologics have revolutionised treatment of RA. More recently, the emergence of high-quality biosimilars has provided a cost-effective means of…
9
Mins
29 Jul 2019
Considering the Patient Perspective: Challenges Facing Women with Axial Spondyloarthritis and Psoriatic Arthritis
Although gender is defined by psychological and social differences between men and women, and sex is defined by biological parameters based on genetics…
11
Mins
29 Jul 2019
Metacognition in Rheumatoid Arthritis: Thinking About Our Thinking in Rheumatoid Arthritis Management
Since the 1990s, outcomes for patients with RA have steadily improved over time, with the treatment target for patients evolving from symptomatic relief…
10
Mins
29 Jul 2019
Fine-Tuning the Treatment of Psoriatic Arthritis: Focus on the IL-23 Pathway
The aim of this symposium was to familiarise participants with the IL-23 pathway and the rationale for targeting this pathway in PsA…
9
Mins
29 Jul 2019
Editor’s Pick: Immunometabolism in Rheumatic Disease: The Role in Pathogenesis and Implications for Treatment
The field of immunometabolism is a rapidly expanding area of research that centres around understanding the interrelationship between immunological and…
10
Mins
29 Jul 2019
Postmenopausal Osteoporosis: A Mini Review
Osteoporosis is a systemic skeletal disease characterised by microarchitectural deterioration and high fragility of bone tissue, resulting in low bone…
11
Mins
29 Jul 2019
Update on the Diagnosis and Anticoagulant Treatment of the Antiphospholipid Syndrome
Although aPL are reported in 1–5% of the general population,2 only a minority of these individuals will develop the clinical manifestations of APS. The incidence of APS…
11
Mins
29 Jul 2019
Secukinumab in the Management of Psoriatic Arthritis: Current Perspectives
Psoriatic arthritis (PsA) belongs to the group of diseases known as spondyloarthritis (SpA). The impact of PsA is not limited to just skin and joints…
8
Mins
29 Jul 2019
A Review of Adalimumab Biosimilars for the Treatment of Immune-Mediated Rheumatic Conditions
Adalimumab is a recombinant fully human monoclonal antibody (IgG1 type) targeting soluble and transmembrane TNF. AbbVie’s bio-originator adalimumab…
5
Mins
29 Jul 2019
Real-World Experience of Apremilast in Treating Psoriatic Arthritis Patients with Comorbidities
Apremilast (APR) is a small molecule phosphodiesterase-4 inhibitor that is used in the treatment of psoriasis (PsO) and psoriatic arthritis (PsA)…
9
Mins
13 Dec 2018
Central Processes Underlying Fibromyalgia
Fibromyalgia is a common chronic pain disorder characterised by a robust clinical phenotype with principal features that include widespread pain and…
9
Mins
13 Dec 2018
Drilling Down to the Bone: Evaluating Bone Marrow Lesions in Osteoarthritis
Osteoarthritis (OA) is the most prevalent form of arthritis worldwide and affects the whole joint. Changes in cartilage integrity, subchondral bone, and…
9
Mins
13 Oct 2018
Effect of Mesenchymal Stem Cells in Autoimmune Arthritis
The most common autoimmune diseases that affect the joints are osteoarthritis (OA) and rheumatoid arthritis (RA). The pathogeneses of both OA and RA are…
10
Mins
4 Sep 2018
Switching from Reference to Biosimilar Products: An Overview of the European Approach and Real-World Experience So Far
Switching patients from a reference to a biosimilar product has become a primary topic of interest, with different approaches being undertaken by the…
9
Mins
4 Sep 2018
Knee Infection After Anterior Cruciate Ligament Reconstruction
This article presents a case of infection after ACL reconstruction and discusses risk factors, treatment choice, antibiotic treatment length, and functional outcomes, proposing a guide for the treatment.
11
Mins
4 Sep 2018
The Role of Nicotinamide Adenine Dinucleotide in the Pathogenesis of Rheumatoid Arthritis: Potential Implications for Treatment
The aim of this review is to illustrate the role of NAD+-related enzymes in the pathogenesis of RA and highlight the potential therapeutic role of NAD+ in RA.
9
Mins
31 Jul 2018
Anti-TNF in Rheumatic Diseases: Inventory and Outlook
With an increasing number of biosimilars receiving regulatory approval, the treatment landscape for rheumatic diseases is evolving. Healthcare…
8
Mins
31 Jul 2018
Editor's Pick: JAK Inhibitors in the Treatment Algorithm of Rheumatoid Arthritis: A Review
Biological disease-modifying antirheumatic drugs have defined a new era in rheumatoid arthritis (RA) management but share the limitation of antagonising…
10
Mins
31 Jul 2018
Switching to Biosimilars in Inflammatory Rheumatic Conditions: Current Knowledge
Biosimilars are more affordable versions of previously approved biopharmaceuticals that are designed to reduce healthcare expenditure and increase…
9
Mins
31 Jul 2018
Primary Sjögren’s Syndrome in the Elderly: Does Age of Onset Make a Difference?
Primary Sjögren’s syndrome (pSS) is a relatively common disease and one of the most common rheumatic diseases
10
Mins
31 Jul 2018
Cytokines and Inflammatory Mediators in Systemic Lupus Erythematosus
Systemic lupus erythematosus (SLE) is an autoimmune disease characterised by a breakdown in immune tolerance
9
Mins
31 Jul 2018
Disease-Modifying Antirheumatic Diets: The New Treatment Modalities for Rheumatoid Arthritis
Autoimmune responses need to be identified and managed promptly to avoid deleterious consequences. Autoimmune diseases, such as rheumatoid arthritis (RA)…
9
Mins
31 Jul 2018
Stroke and Systemic Lupus Erythematosus: A Review
This review analyses the factors responsible for higher ischaemic and haemorrhagic stroke risk in the systemic lupus erythematosus population
28 Jul 2018
A UK Best Practice Model for Diagnosis and Treatment of Axial Spondyloarthritis
Objectives: To examine the combined effectiveness of a care pathway for patients with suspected inflammatory back pain (IBP) in conjunction with an…
6
Mins
13 Mar 2018
The Journey to Motherhood in Chronic Rheumatic Diseases
Prof Taylor opened the meeting and briefly highlighted the epidemiology of pregnancy in women with chronic rheumatic diseases. Dr Moltó presented the…
8
Mins
1 Mar 2018
European League Against Rheumatism Recommendations for Early Arthritis: What Has Changed?
Rheumatoid arthritis (RA) is a chronic, disabling, inflammatory, autoimmune disease that affects approximatively 0.4–1.0% of the population. Immune…
9
Mins
1 Mar 2018
Osteoarthritis and Ageing
Osteoarthritis (OA) is the most common global chronic joint disease. A study into the impact of Osteoarthritis and its impact on ageing
9
Mins
1 Dec 2017
Considering Patients’ Needs: Action and Reaction of Interleukin-6 Blockade
The objective of the symposium was to explain the mechanism behind IL-6 dysfunction in RA pathophysiology, review novel RA therapies…
8
Mins
1 Dec 2017
Interleukin-23: The Common Link Between the Joint, the Gut, and the Skin?
Prof McGonagle introduced the symposium and briefly described the aims of the meeting.
7
Mins
30 Nov 2017
The Treatment Approach of Idiopathic Inflammatory Myopathies
This commentary reflects our personal approach to the treatment of idiopathic inflammatory myopathies (IIM), also commonly referred to as myositis.
9
Mins
30 Nov 2017
Ankylosing Spondylitis: A Review
Ankylosing spondylitis is a chronic autoimmune inflammatory condition belonging to the spondyloarthropathy category of rheumatic diseases…
9
Mins
20 Nov 2017
Time To Control Gout and Make It Crystal Clear
Prof Fernando Perez-Ruiz opened the symposium, which focussed on the current unmet need in controlling gout and associated comorbidities with current…
7
Mins
26 Oct 2017
The International Osteoporosis Foundation Continues Campaign to Raise Awareness of Osteoporosis
To mark this year’s World Osteoporosis Day (WOD) on the 20th October 2017, the European Medical Journal spoke to the International Osteoporosis…
3
Mins
9 Aug 2017
Spasmodic Dysphonia: What About It?
Spasmodic dysphonia (SD): what about it? That is the million-dollar question.
11
Mins
1 Aug 2017
Biosimilars and Switching: What is your Perspective?
The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases.
9
Mins
1 Aug 2017
Switching Patients from Originator to Biosimilar Medications in Rheumatoid Arthritis: Limiting The ‘Nocebo’ Effect
Biosimilars have been available in Europe since 2006, and biosimilars of monoclonal antibodies since 2013, and are now a widespread clinical reality.
9
Mins
1 Aug 2017
The Patient’s Perspective on Psoriatic Arthritis: What more can Rheumatologists do to Optimise Disease Management?
The symposium at the EULAR 2017 congress aimed to provide insights into the burden of psoriatic arthritis on patients’ daily lives, including the…
9
Mins
1 Aug 2017
Editor’s Pick: Why do Diseases Start One Sided? Clues From HLA-B27 Acute Anterior Uveitis
Uveitis is an inflammatory disease with significant disease burden, as it causes ≤10% of legal blindness in the USA.
8
Mins
1 Aug 2017
Osmolytes as Mediators of the Muscle Tissue’s Responses to Inflammation: Emerging Regulators of Myositis with Therapeutic Potential
In this review, the role of the organic osmolytes taurine, betaine, myo-inositol, and sorbitol in skeletal muscles in general, and in myositis in…
10
Mins
1 Aug 2017
Advances in Epigenetics and Integration of Omics in Lupus
Systemic lupus erythematosus is a chronic, multi-organ disease that predominantly affects young women of childbearing age.
7
Mins
1 Aug 2017
Nanomedicines for Increased Specificity and Therapeutic Efficacy of Rheumatoid Arthritis
Rheumatoid arthritis, the most frequent chronic inflammatory autoimmune disease, can lead to pain, bone and articular destruction, and limb…
9
Mins
1 Aug 2017
Vitamin D Deficiency and Chronic Widespread Pain
Vitamin D acts as a steroid hormone possessing important functions in calcium and phosphorus balance and bone health.
4
Mins
12 Jun 2017
Humane Resources: Funding Restrictions in Rare Rheumatic Diseases
As any rheumatologist knows, most non-medical individuals don’t really know what ‘rheumatology’ is. Not so much of a bad reputation, as no reputation.
10
Mins
2 Mar 2017
New Drug Treatments for Osteoarthritis: What Is on the Horizon?
Osteoarthritis (OA) is the most common form of arthritis, yet has historically lagged far behind rheumatoid arthritis in terms of drug development.
9
Mins
2 Mar 2017
Antiphospholipid Syndrome and the Lungs
Antiphospholipid syndrome (APS) is a systemic autoimmune disease characterised by recurrent thromboembolic events (arterial or venous) and/or morbidity…
19 Dec 2016
Epigenetic Mechanisms in Sjögren’s Syndrome
Primary Sjögren’s syndrome (pSS) is a systemic autoimmune epithelitis and recent advances in our comprehension of its pathophysiology strongly suggest a…
13 Dec 2016
Editor’s Pick: Ocular Manifestations of Whiplash Injury
Introduction: Whiplash or indirect injuries to the neck are a common occurrence because of motor vehicle collisions, in which the frequency of ocular…
26 Aug 2016
The Evolving Landscape of Rheumatology: Biosimilarity and Extrapolation
Targeted biological therapies have revolutionised the treatment of inflammatory diseases in rheumatology and new agents continue to be developed. The…
23 Aug 2016
Editor’s Pick: Clinical Management of Fibromyalgia and the Continuum of Polysymptomatic Distress Disorders
The evaluation of patients with fibromyalgia (FM) and other functional somatic syndromes can appear intimidating, but a high index of suspicion and a…
23 Aug 2016
The Evolving Biosimilar Landscape: Approval of the First Etanercept Biosimilar in Europe, An Interview With Emilio Martín-Mola
On January 14th 2016, SB4 (Benepali®) received marketing authorisation application approval from the European Commission (EC). It is the first biosimilar…
23 Aug 2016
Spondyloarthritis: Pathogenesis, Clinical Manifestations, Diagnosis and Management
The term spondyloarthritis (SpA) is used to describe a heterogeneous group of diseases sharing certain characteristics.
26 Jul 2016
Introducing New Biosimilars Into Current Treatment Algorithms
Three biosimilar products are now licensed for the treatment of rheumatic diseases in Europe. The European Medicines Agency (EMA) requires that similarity between a biosimilar and its reference product is demonstrated using a rigorous, stepwise process that includes extensive physicochemical and biological analytical testing, non-clinical pharmacology, clinical evaluations, and pharmacovigilance plans. Each
26 Jul 2016
Optimising Patient Outcomes Throughout the Rheumatoid Arthritis Patient Journey: The Exception, the Standard, and the Rule
Prof Peter Taylor opened the symposium focussed on optimisation of treatment for rheumatoid arthritis (RA) at each stage of the patient’s journey. Prof…
26 Jul 2016
Unravelling the Mystery Between Structure and Sustained Clinical Outcomes
Targeted biologics have revolutionised the treatment and outlook of patients with inflammatory joint diseases. The combination of high-cost long-term…
26 Jul 2016
Precision Medicine: Maximising Treatment Benefit for Rheumatoid Arthritis Patients
This educational symposium was opened by Prof Ernest Choy, who introduced the concept of precision medicine and highlighted the importance of integrating…
26 Jul 2016
Think Rheumatoid Arthritis: Causes, Consequences, and Management
Prof Josef Smolen opened the symposium and briefly described the aims of the meeting. Co-host Prof Constantino Pitzalis first discussed the…
26 Jul 2016
Editor’s Pick: TYRO3, AXL, and MERTK Receptor Tyrosine Kinases: Is There Evidence of Direct Involvement in Development and Onset of Sjögren’s Syndrome?
Sjögren’s syndrome (SjS) is a chronic, progressive, systemic, human autoimmune disease in which an auto-inflammatory process within the salivary and…
26 Jul 2016
The Relevance of Hyperuricaemia
The aim of the present review is to summarise the results from recent clinical studies on the basis of the newly proposed temporal classification of…
26 Jul 2016
Non-Invasive Cardiovascular Imaging for Cardiovascular Risk Assessment in Rheumatoid Arthritis
People with rheumatoid arthritis (RA) are often under-recognised as a group with elevated risk of cardiovascular (CV) disease and increased morbidity…
26 Jul 2016
Psoriatic Arthritis: A Review
Psoriatic arthritis is an inflammatory arthritis which affects the skin and musculoskeletal system. If not diagnosed early and treated effectively it can…
26 Jul 2016
Therapies in the Pipeline for Systemic Autoimmune Diseases
The current goals in the development of novel therapeutics of systemic autoimmune diseases are to develop agents more effective than conventional…
26 Jul 2016
Idiopathic Inflammatory Myopathies; Association with Overlap Myositis and Syndromes: Classification, Clinical Characteristics, and Associated Autoantibodies
Idiopathic inflammatory myopathies (IIM) are traditionally identified as a group of disorders that target skeletal muscle due to autoimmune dysfunction…
3
Mins
12 Jul 2016
A Call from a Patient to Openly Discuss Body Image in the Treatment of Type 1 Diabetes
Diabetes is a non-communicable disease (NCD) meaning that it often cannot be seen. After 20 years of living with Type 1 diabetes I am lucky to have no…
21 Apr 2016
From Bench to Bedside: Targeting the IL-1β Pathway in Autoinflammatory Diseases
Prof Gerd Horneff opened the symposium with a summary of the recent advances in the understanding of the role of interleukin (IL)-1β in the pathogenesis…
21 Apr 2016
American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) 2015 Meeting Highlights: New Data on Canakinumab
nterleukin (IL)-1 is a messenger for the regulation of inflammatory responses, but it can be harmful when in excess, such as in the inflammation observed…
28 Jul 2015
IL-17 Inhibition: Emerging Perspectives in the Future Management of Axial Spondyloarthritis
The meeting was opened by Prof Atul Deodhar who introduced the prevalence, epidemiology, and clinical features of axial spondyloarthritis (axSpA), and…
28 Jul 2015
IL-17 Inhibition in Spondyloarthritis: A Targeted Approach in Psoriatic Arthritis
Prof Philip Mease introduced psoriatic arthritis (PsA) with a particular emphasis on disease symptoms and an update on the status of current disease…
28 Jul 2015
Pregnancy in Chronic Arthritis: Only a Matter of Planning
Chronic arthritis often affects women of childbearing age. The old concept that having chronic arthritis constitutes a major obstacle to women when…
28 Jul 2015
Obesity and Osteoarthritis: More Than Just Mechanics
Osteoarthritis (OA) is the most common form of arthritis worldwide. It results in chronic pain, functional limitations, and significant social and…
28 Jul 2015
Diffuse Large B Cell Lymphoma of the Foot in a Patient with Rheumatoid Arthritis
Patients with rheumatoid arthritis (RA) have an increased risk of developing malignant lymphomas, especially non-Hodgkin’s lymphoma (NHL).
28 Jul 2015
Deciphering Ectopic Calcification: Contribution of the Rare, Inherited Disorder Pseudoxanthoma Elasticum
Soft connective tissue calcification is still an intriguing problem due to the high number of genes, proteins, and enzymes involved in the process.
28 Jul 2015
Axial Spondyloarthritis: An Evolving Concept
Axial spondyloarthritis (AxSpA) is the prototype of a family of inter-related yet heterogeneous diseases sharing common clinical and genetic…
3
Mins
27 Feb 2015
Big Ben, Covent Garden, and the Thames: Lessons Learned from a Visit to London—Collaboration Improves Outcomes
This past week I have had the honour and pleasure of introducing my book Women and Cardiovascular Disease in London. During the book-signing event, I was…
25 Jul 2014
Osteoarthritis: The Challenge of Establishing a Personalised Treatment
The symposium, co-chaired by Prof Johanne Martel-Pelletier and Prof Antonello Pietrangelo, opened with a discussion of metabolic syndrome-associated…
25 Jul 2014
Innate Immunity in Systemic Sclerosis – Role of Toll-Like Receptors, Interferon, and the Potential Impact of Vitamin D
Systemic sclerosis (SSc) is an autoimmune disease in which vascular damage and immune activation leads to excessive accumulation of extracellular matrix…
25 Jul 2014
Idiopathic Scoliosis
Idiopathic scoliosis (IS) is a lifetime condition and is defined as a structural, lateral rotated curvature of the spine of >10° on standing coronal…
25 Jul 2014
Osteoporosis-Related Mortality: Time-Trends and Predictive Factors
Osteoporosis is one of the leading causes of handicap worldwide and a major contributor to the global burden of diseases. In particular, osteoporosis is…
25 Jul 2014
Use of Ultrasound for Diagnosis and Follow-Up of Psoriatic Arthritis
Musculoskeletal ultrasound (US) is increasingly used as a bedside tool for diagnostic and monitoring purposes in patients with psoriatic arthritis (PsA).
25 Jul 2014
Update on Genetic Susceptibility and Pathogenesis in Juvenile Idiopathic Arthritis
Juvenile idiopathic arthritis (JIA) is a multifactorial disease with a pathogenesis which remains inexplicable. However, genome-wide association studies…
25 Jul 2014
The Importance of the mTOR Regulatory Network in Chondrocyte Biology and Osteoarthritis
Osteoarthritis (OA) is a chronic disorder associated mainly with pain, limited range of motion, stiffness, joint inflammation, and articular cartilage…
25 Jul 2014
Why Basic Calcium Phosphate Crystals Should Be Targeted In the Treatment of Osteoarthritis
Osteoarthritis (OA) is the most common form of arthritis and results in significant social, psychological, and economic costs. It is characterised by…
25 Jul 2014
Extra-Articular Manifestations of Rheumatoid Arthritis, Now
Rheumatoid arthritis (RA) is a chronic systemic inflammatory disease, characterised by polyarthritis and extra-articular organ disease, including…
25 Jul 2014
Antiphospholipid Syndrome Novel Therapies
Antiphospholipid syndrome (APS) is an autoimmune disease characterised by arterial and/or venous thrombosis, recurrent pregnancy loss, and persistently…
Loading posts...
« Previous
1
…
19
20
21
We’ve noticed you’re accessing
from
North/South America.
View
View